IL-6 can also promote osteoclastic activity and bone loss by activating the osteoprotegerin/receptor activator of nuclear factor kappa B ligand/receptor activator of the nuclear factor kappa B (OPG/RANKL/RANK) system, leading to osteoporosis [23]. This evidence concerns the gene TNFRSF11A and osteoporosis.